{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:26:50Z","timestamp":1791473210393,"version":"4.3.4"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>CAR T cell therapy achieves high degrees of success with respect to complete response and overall response rates in many hematological cancers, especially lymphomas. Compared to other immunotherapies, these \u201cactivated\u201d blood products are plagued by a high incidence of a severe systemic inflammatory response syndrome, resulting from the exaggerated release of cytokines, chemokines, and other pro-inflammatory protein and lipid mediators. These can produce what is known as the \u201ccytokine release syndrome\u201d (CRS), associated with significant morbidity and mortality. Although successful CAR T cell therapy reduces the tumor load, the killing of large numbers of cancer cells and the persistence of apoptotic cellular debris within the tumor microenvironment (TME) may also be tumorigenic. We propose a single active pharmaceutical ingredient (API), the highly polyunsaturated omega-3 fatty acids eicosapentaenoic and docosahexaenoic acids, applying a refined and enriched fish oil, with multiple therapeutic targets that can be administered in precise doses. First, they rapidly modulate the intensity of the systemic inflammatory response, by modifying eicosanoid metabolism via intravenous administration. Second, as substrates for the production of specialized pro-resolving mediators (SPMs) of inflammation, they can help clear cellular debris within the TME, perhaps reducing the risks of new tumor formation. The employment of such a drug either in a prophylactic and\/or a treatment manner might further improve the outcome of CAR T cell therapy.<\/jats:p>","DOI":"10.3389\/fphar.2025.1615526","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:04:08Z","timestamp":1749564248000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment"],"prefix":"10.3389","volume":"16","author":[{"given":"David F.","family":"Driscoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Bistrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/1878-0261.13618","article-title":"From monocyte-derived macrophages to resident macrophages\u2014how metabolism leads their way in cancer","volume":"18","author":"Ammarah","year":"2024","journal-title":"Molec. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1084\/jem.102.5.499","article-title":"Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of typhoid vaccine","volume":"102","author":"Atkins","year":"1955","journal-title":"J. Exp. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/viru.27135","article-title":"Systemic inflammatory response (SIRS). Where did it come from? And is it still relevant?","volume":"5","author":"Balk","year":"2014","journal-title":"Virulence"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.4049\/jimmunol.135.6.3969","article-title":"Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells","volume":"135","author":"Beutler","year":"1985","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00003246-199903000-00004","article-title":"Acute phase proteins and the systemic inflammatory response","volume":"27","author":"Bistrian","year":"1999","journal-title":"Crit. Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0148607103027003168","article-title":"Clinical aspects of essential fatty acid metabolism: jonathan Rhoads Lecture","volume":"27","author":"Bistrian","year":"2003","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM consensus conference committee. American college of chest physicians\/society of critical care medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/cei\/uxac055","article-title":"Increased TNF-\u03b1 production in response to IL-6 in patients with systemic inflammation without infection","volume":"209","author":"Cabrera-Rivera","year":"2022","journal-title":"Clin. Exper. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1476565","DOI":"10.3389\/fimmu.2024.1476565","article-title":"Mechanistic studies of tumor-associated macrophage immunotherapy","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3945\/ajcn.2009.27951","article-title":"Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish oil emulsion in humans","volume":"91","author":"Carpentier","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000170104","article-title":"Tumor necrosis factor as a mediator of shock, cachexia and inflammation","volume":"11","author":"Cerami","year":"1993","journal-title":"cachexia Inflamm. Blood Purif"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.3390\/cancers14235983","article-title":"Efficacy, safety, and challenges of CAR T-Cells in the treatment of solid tumors","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.3390\/ijms24076300","article-title":"CAR T Cell Therapy: a versatile living drug","volume":"24","author":"De Marco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/clinids\/6.1.51","article-title":"Interleukin-1","volume":"6","author":"Dinarello","year":"1984","journal-title":"Rev. Infect. Dis."},{"key":"B18","first-page":"87","article-title":"Interleukin 1 receptors and biological responses","volume":"63","author":"Dinarello","year":"1990","journal-title":"Yale J. Biol. Med."},{"key":"B19","first-page":"1","article-title":"Interleukin-1 and its receptor","volume":"9","author":"Dinarello","year":"1989","journal-title":"Crit. Rev. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/0148607116673187","article-title":"Pharmaceutical and clinical aspects of lipid injectable emulsions: jonathan Rhoads Lecture","volume":"41","author":"Driscoll","year":"2017","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/jpen.2507","article-title":"Proinflammatory mediators in lipid emulsions and parenteral nutrition\u2013associated liver disease: review of leading factors","volume":"47","author":"Driscoll","year":"2023","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e23066","DOI":"10.1096\/fj.20230.0396R","article-title":"Cytokine storm associated with severe COVID-19 infections: the potential mitigating role of omega-3 fatty acid triglycerides in the ICU","volume":"37","author":"Driscoll","year":"2023","journal-title":"FASEB J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.xphs.2024.04.027","article-title":"Pharmaceutical considerations and metabolic fate of parenteral lipid nanoparticle dosage forms","volume":"113","author":"Driscoll","year":"","journal-title":"J. Pharm. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/cnr2.70025","article-title":"Cytokine release syndrome associated with immune-modulating chemotherapy: potential mitigating role of intravenous omega-3 fatty acid triglycerides","volume":"7","author":"Driscoll","year":"","journal-title":"Cancer Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clnu.2008.05.003","article-title":"Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology","volume":"27","author":"Driscoll","year":"2008","journal-title":"Clin. Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijpharm.2009.06.021","article-title":"Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: globule size distribution (GSD) and fatty acid analyses","volume":"379","author":"Driscoll","year":"2009","journal-title":"Int. J. Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/0148607184008002174","article-title":"In vitro leukocyte endogenous mediator production is not impaired following surgical stress in moderately malnourished patients","volume":"8","author":"Duncan","year":"1984","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM1.98902.02320.0501","article-title":"The effect of dietary supplementation with n3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"107670","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: failure of resolution of inflammation?","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2466261","DOI":"10.1080\/16078454.2025.2466261","article-title":"The role of non-malignant B cells in malignant hematological diseases","volume":"20","author":"Gao","year":"2025","journal-title":"Hematology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1097\/CCM.0000000000006626","article-title":"Omega-3 polyunsaturated fatty acids in sepsis: from prevention to early treatment","volume":"53","author":"Giamarellos-Bourboulis","year":"2025","journal-title":"Crit. Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/s0022-2275(20)37575-1","article-title":"Incorporation of medium chain triacylglycerols into phospholipid bilayers: effect of long chain triacylglycerols, cholesterol, and cholesteryl esters","volume":"37","author":"Hamilton","year":"1996","journal-title":"J. Lipid Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.jlr.2021.100113","article-title":"Omega-3 versus omega-6 fatty acid availability is controlled by hydrophobixc geometries of phospholipid A2s","volume":"62","author":"Hayashi","year":"2021","journal-title":"J. Lipid Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00281-024-01013-w","article-title":"Riding the storm: managing cytokine-related toxicities in CAR T-cell therapy","volume":"46","author":"Hughes","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"101605","DOI":"10.1016\/j.smim.2022.101605","article-title":"Specialized pro-resolving mediators as modulators of immune responses","volume":"59","author":"Julliard","year":"2022","journal-title":"Semin. Immunol."},{"key":"B38","first-page":"844","article-title":"An altered response by peripheral leukocytes to synthesize or release leukocyte endogenous mediator in critically ill, protein-malnourished patients","volume":"100","author":"Keenan","year":"1982","journal-title":"J. Clin. Lab. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00000658\u201319960-3000\u201300013","article-title":"Early enteral feeding in postsurgical cancer patients: fish oil structured lipid-based polymeric formula versus a standard polymeric formula","volume":"223","author":"Kenler","year":"1996","journal-title":"Ann. Surg."},{"key":"B40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1084\/jem.107.2.291","article-title":"Studies on the pathogenesis of fever. IV. The site of action of leucocytic and circulating endogenous pyrogen","volume":"107","author":"King","year":"1958","journal-title":"J. Exp. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"106854","DOI":"10.1016\/j.prostaglandins.2024.106854","article-title":"EPA, DHA, and resolvin effects on cancer risk: the underexplored mechanisms","volume":"174","author":"Kiyasu","year":"2024","journal-title":"Prostgl. Other Lip. Mediat."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"vdaf059","DOI":"10.1093\/noajnl\/vdaf059","article-title":"Chimeric antigen receptor-macrophages: emerging next-generation cell therapy for brain cancer","volume":"7","author":"Koppers","year":"2025","journal-title":"Adv"},{"key":"B44","doi-asserted-by":"publisher","first-page":"702785","DOI":"10.3389\/fimmu.2021.702785","article-title":"Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities","volume":"12","author":"Lavy","year":"2021","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1378944","DOI":"10.3389\/fimmu.2024.1378944","article-title":"Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives","volume":"15","author":"Levstek","year":"2024","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40164-024-00549-9","article-title":"The next frontier in immunotherapy: potential and challenges of CAR-macrophages","volume":"13","author":"Li","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1182\/bloodadvances.2024013146","article-title":"CAR T-cell expansion: harmful or helpful?","volume":"8","author":"Lionel","year":"2024","journal-title":"Blood Adv."},{"key":"B48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-022-03813-w","article-title":"Targeting macrophages: a novel treatment strategy in solid tumors","volume":"20","author":"Liu","year":"2022","journal-title":"J. Transl. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e253455","DOI":"10.1001\/jamanetworkopen.2025.3455","article-title":"Cytokine storms in COVID-19, hemophagocytic lymphohistiocytosis, and CAR-T therapy","volume":"8","author":"Long","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"B50","doi-asserted-by":"publisher","first-page":"106439","DOI":"10.1016\/j.jff.2024.106439","article-title":"Pro-resolving metabolites: future of fish oil supplements. J Funct","volume":"121","author":"Maliha","year":"2024","journal-title":"Foods"},{"key":"B51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","article-title":"Humoral innate immunity and acute phase proteins","volume":"388","author":"Mantovani","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms23031328","article-title":"The apoptosis paradox in cancer","volume":"23","author":"Morana","year":"2022","journal-title":"Int. J. Molec. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1097\/CCM.0000000000006593","article-title":"Association of omega-3 status with long-term risk of hospitalization for sepsis","volume":"53","author":"Narayan","year":"2025","journal-title":"Crit. Care Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s43018-023-00524-z","article-title":"Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway","volume":"4","author":"Park","year":"2023","journal-title":"Nat. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0148607188012002212","article-title":"Role of biochemical mediators in clinical nutrition and surgical metabolism","volume":"12","author":"Pomposelli","year":"1988","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"106944","DOI":"10.1016\/j.prostaglandins.2024.10694","article-title":"Exploring the unique role of specialize pro-resolving mediators in cancer therapeutics","volume":"23","author":"Quinlivan","year":"2024","journal-title":"Prostagl. Other Lip. Mediat"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archinte.1970.00310120093014","article-title":"Physiology and physiopathology of the reticuloendothelial system","volume":"126","author":"Saba","year":"1970","journal-title":"Arch. Int. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1462307","DOI":"10.3389\/fmed.2024.1462307","article-title":"The current socioeconomic and regulatory landscape of immune effector cell therapies","volume":"11","author":"Sainatham","year":"2024","journal-title":"Front. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1012908","DOI":"10.1371\/journal.pcbi.1012908","article-title":"Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome","volume":"21","author":"Santurio","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10555-023-10091-5","article-title":"Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next pandemic?","volume":"42","author":"Serhan","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1190379","DOI":"10.3389\/fimmu.2023.1190379","article-title":"Cytokine release syndrome and cancer immunotherapies \u2013 historical challenges and promising futures","volume":"14","author":"Shah","year":"2023","journal-title":"Front. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3181\/0711-MR-311","article-title":"The importance of the omega-6\/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases","volume":"233","author":"Simopoulis","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1084\/jem.20170681","article-title":"Resolvins suppress tumor growth and enhance cancer therapy","volume":"215","author":"Sulciner","year":"2018","journal-title":"J. Exp. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1097\/00003246-199310001-00002","article-title":"Tumor necrosis factor: an updated review of its biology","volume":"21","author":"Tracey","year":"1993","journal-title":"Crit. Care Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0148607181005003230","article-title":"Development of fat emulsions","volume":"5","author":"Wretlind","year":"1981","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-024-01977-1","article-title":"Crosstalk between metabolism and cell death in tumorigenesis","volume":"23","author":"Yang","year":"2024","journal-title":"Molec. Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"117296","DOI":"10.1016\/j.biopha.2024.117296","article-title":"Exosome-based nanoparticles and cancer immunotherapy","volume":"179","author":"Ye","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s41232-024-00358-x","article-title":"Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy","volume":"44","author":"Zhang","year":"2024","journal-title":"Inflamm. Regen."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1551583","DOI":"10.3389\/fonc.2025.1551583","article-title":"Cell-based immunotherapies for solid tumors: advances, challenges, and future directions","volume":"15","author":"Zhao","year":"2025","journal-title":"Front. Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1157537","DOI":"10.3389\/fimmu.2023.1157537","article-title":"Targeting myeloid-derived suppressor cells in tumor immunotherapy: current, future and beyond","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1615526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:04:10Z","timestamp":1749564250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1615526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":73,"alternative-id":["10.3389\/fphar.2025.1615526"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1615526","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1615526"}}